Also, the dual-immune regulation strategy targeting tumor-responsive PD-L1 and Cox-2 proved to be more effective compared to strategies focused solely on PD-L1 or Cox-2 in inhibiting tumor growth, preventing metastasis, and avoiding relapse. This evidence concerns the gene CD274 and neoplasm.